These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 15749124

  • 21. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.
    Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, Collins PL.
    Proc Natl Acad Sci U S A; 2004 Jun 29; 101(26):9804-9. PubMed ID: 15210961
    [Abstract] [Full Text] [Related]

  • 22. Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.
    Du L, Zhao G, Chan CC, Sun S, Chen M, Liu Z, Guo H, He Y, Zhou Y, Zheng BJ, Jiang S.
    Virology; 2009 Oct 10; 393(1):144-50. PubMed ID: 19683779
    [Abstract] [Full Text] [Related]

  • 23. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J, Cao Y, Du J, Bu X, Ma R, Wu C.
    Vaccine; 2007 Sep 28; 25(39-40):6981-91. PubMed ID: 17709158
    [Abstract] [Full Text] [Related]

  • 24. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
    Zhang Y, Yang F, Li YH, Li WH, Tu XM, Wei Q, Zhu H, Liu L, Wang H, Qin C, Yuan GY, He W, Wang SH.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep 28; 18(3):258-60. PubMed ID: 15640862
    [Abstract] [Full Text] [Related]

  • 25. A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity.
    Du L, Zhao G, Chan CC, Li L, He Y, Zhou Y, Zheng BJ, Jiang S.
    Viral Immunol; 2010 Apr 28; 23(2):211-9. PubMed ID: 20374001
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
    See RH, Zakhartchouk AN, Petric M, Lawrence DJ, Mok CPY, Hogan RJ, Rowe T, Zitzow LA, Karunakaran KP, Hitt MM, Graham FL, Prevec L, Mahony JB, Sharon C, Auperin TC, Rini JM, Tingle AJ, Scheifele DW, Skowronski DM, Patrick DM, Voss TG, Babiuk LA, Gauldie J, Roper RL, Brunham RC, Finlay BB.
    J Gen Virol; 2006 Mar 28; 87(Pt 3):641-650. PubMed ID: 16476986
    [Abstract] [Full Text] [Related]

  • 34. Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus.
    Ba L, Yi CE, Zhang L, Ho DD, Chen Z.
    Appl Microbiol Biotechnol; 2007 Oct 28; 76(5):1131-6. PubMed ID: 17581748
    [Abstract] [Full Text] [Related]

  • 35. Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals.
    Zhu Y, Yu D, Han Y, Yan H, Chong H, Ren L, Wang J, Li T, He Y.
    Sci Adv; 2020 Nov 28; 6(45):. PubMed ID: 33036961
    [Abstract] [Full Text] [Related]

  • 36. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
    Sui J, Deming M, Rockx B, Liddington RC, Zhu QK, Baric RS, Marasco WA.
    J Virol; 2014 Dec 28; 88(23):13769-80. PubMed ID: 25231316
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.